GRAFTECH INTERNATIONAL LTD. - 2006 Annual Report (10-K) Summary
Business Context and Reporting Period
This report covers the fiscal year ended December 31, 2006. GrafTech International Ltd. is a global manufacturer of graphite electrodes, advanced graphite materials, carbon refractories, and natural graphite products. The company serves the steel, electronics, semiconductor, transportation, and petrochemical industries. A significant strategic shift occurred in the fourth quarter of 2006 with the sale of its cathode business (including a 70% interest in Carbone Savoie), which is now reported as discontinued operations. The company operates 11 manufacturing facilities across four continents.
Key Financial Metrics (2006)
| Metric | 2006 Value | 2005 Value |
|---|---|---|
| Net Sales | $855.4 million | $773.0 million |
| Gross Profit | $249.3 million | $219.2 million |
| Gross Margin | 29.1% | 28.4% |
| Net Income | $91.3 million | ($125.2 million) Loss |
| Operating Cash Flow | $64.2 million | $8.0 million |
| Total Debt | $665.4 million | $703.7 million |
| Cash and Equivalents | $149.5 million | $6.0 million |
| Stockholders' Deficit | ($113.9 million) | ($209.6 million) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 10.7% to $855.4 million, driven by a 15.0% increase in graphite electrode sales (due to higher volumes and prices) and a 17.2% increase in advanced graphite materials sales.
- Profitability Turnaround: The company returned to profitability with $91.3 million in net income, compared to a $125.2 million loss in 2005. This improvement was significantly aided by a $58.6 million pre-tax gain from the sale of the discontinued cathode business.
- Segment Performance: The Graphite Electrode segment operating income rose to $115.4 million. Conversely, the "Other Businesses" segment (including natural graphite and carbon electrodes) reported an operating loss of $14.4 million, largely due to the planned exit of the carbon electrode business.
- Debt Reduction: Total debt decreased by approximately $38 million. In early 2007, the company redeemed $120 million of Senior Notes and planned to redeem an additional $15 million.
- Restructuring and Impairments: The company recorded $10.0 million in restructuring charges and $10.5 million in impairment losses, primarily related to facility rationalizations and the abandonment of an enterprise resource planning system.
Guidance, Outlook, and Risks
- 2007 Outlook: Management expects 2007 net sales of graphite electrodes to increase approximately 15% over 2006. Global EAF steel production is expected to grow by 2%, though overall graphite electrode demand is expected to remain flat due to declining specific consumption rates. Advanced graphite materials demand is expected to remain high.
- Cost Pressures: The company anticipates upward pressure on raw material costs, including freight, energy, and petroleum-based materials.
- Capital Expenditures: Expected to be approximately $50 million in 2007.
- Key Risks:
- High Leverage: Significant debt obligations limit financial flexibility and increase vulnerability to economic downturns.
- Commodity Prices: Results are sensitive to fluctuations in raw material (petroleum coke) and energy prices.
- Currency Fluctuations: A substantial portion of sales and operations are outside the U.S., exposing the company to foreign exchange risks.
- Legal and Environmental: Ongoing exposure to antitrust litigation settlements (though largely resolved) and environmental remediation costs.
Investor Verification Checklist
- Discontinued Operations Impact: Verify the sustainability of earnings by analyzing results excluding the one-time $58.6 million gain from the cathode business sale.
- Debt Covenants: Confirm continued compliance with financial covenants (interest coverage and leverage ratios) under the Revolving Facility and Senior Notes, especially given the high debt load.
- Raw Material Supply: Assess the stability of the supply chain for needle coke, particularly given the loss of the Lemont, Illinois production facility by a key supplier.
- Deferred Tax Assets: Review the $200.5 million valuation allowance on deferred tax assets and the company's ability to generate sufficient future taxable income to realize these benefits.
- Carbon Electrode Exit: Monitor the progress and costs associated with the planned complete exit of the carbon electrode business by the end of 2007.